All In MedTech

FDA Clearance Tracker · P820060-S001

ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 31, 1983 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 31, 1983

Approved

Time to decision

56 days

Received Jul 6, 1983. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Device class

Class II

The decision

FDA number
P820060-S001
Device name
ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
Applicant location
Abbott Park, IL
Received
Jul 6, 1983
Decided
Aug 31, 1983
Decision
Approved
Original approval
P820060

Device type

Device class
Class II
Regulation
21 CFR 866.6010

Every decision under product code LOJ

Source documents

Other decisions for Abbott Laboratories

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.